B of A Securities raises Cardinal Health target to $260
B of A Securities analyst Allen Lutz maintained a Buy rating on Cardinal Health (NYSE: CAH) and raised the price target to $260 from $240, signaling confidence in the company's growth prospects.
*this image is generated using AI for illustrative purposes only.
B of A Securities analyst Allen Lutz has maintained a Buy rating on Cardinal Health (NYSE: CAH) and raised the price target to $260 from $240. The adjustment reflects a revised outlook on the company's valuation and market performance.
Rating and Target Details
The firm's decision to uphold the Buy rating suggests confidence in Cardinal Health's operational strength and future growth prospects. The increased price target indicates an expectation of further upside in the stock's value.
| Metric | Value |
|---|---|
| Rating | Buy |
| Previous Price Target | $240 |
| New Price Target | $260 |
Analyst Perspective
Allen Lutz's recommendation underscores a positive sentiment toward Cardinal Health's strategic positioning. The revised target price serves as a benchmark for investors assessing the stock's potential trajectory.
What specific operational factors are driving the increased confidence in Cardinal Health's growth prospects?
How might Cardinal Health's strategic positioning evolve to meet the revised price target expectations?
What potential market trends could further support the stock's upward trajectory?
16
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
